| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
188,370,000 |
| Market
Cap: |
16.70(B) |
| Last
Volume: |
1,778,607 |
Avg
Vol: |
1,398,026 |
| 52
Week Range: |
$76.22 - $99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 811 |
| Guru Rank Value : 0.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
3,625 |
| Total Buy Value |
$0 |
$0 |
$0 |
$314,469 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
116,079 |
189,843 |
233,203 |
571,547 |
| Total Sell Value |
$10,217,149 |
$17,085,208 |
$20,986,230 |
$54,848,304 |
| Total People Sold |
5 |
5 |
6 |
7 |
| Total Sell Transactions |
11 |
17 |
23 |
53 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-05-26 |
4 |
AS |
$27.50 |
$481,250 |
D/D |
(17,500) |
37,876 |
|
- |
|
| Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-05-26 |
4 |
OE |
$14.39 |
$251,825 |
D/D |
17,500 |
55,376 |
|
- |
|
| Davis George Eric |
SVP, General Counsel |
• – – |
2011-05-26 |
4 |
AS |
$27.50 |
$104,500 |
D/D |
(3,800) |
38,151 |
|
- |
|
| Davis George Eric |
SVP, General Counsel |
• – – |
2011-05-26 |
4 |
OE |
$11.74 |
$44,612 |
D/D |
3,800 |
41,951 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-05-26 |
4 |
S |
$27.00 |
$1,093,828 |
D/D |
(40,512) |
43,978 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-05-26 |
4 |
OE |
$17.33 |
$702,073 |
D/D |
40,512 |
84,490 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-05-25 |
4/A |
S |
$26.94 |
$26,944 |
D/D |
(1,000) |
130,093 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-05-25 |
4 |
S |
$26.94 |
$26,944 |
D/D |
(1,000) |
103,093 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-05-25 |
4 |
S |
$27.00 |
$247,779 |
D/D |
(9,177) |
43,978 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-05-25 |
4 |
OE |
$17.33 |
$159,037 |
D/D |
9,177 |
53,155 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-05-24 |
4 |
S |
$26.00 |
$18,408 |
D/D |
(708) |
19,211 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-05-24 |
4 |
OE |
$17.33 |
$12,314 |
D/D |
708 |
19,919 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-05-23 |
4 |
S |
$25.66 |
$24,065 |
D/D |
(938) |
19,211 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-05-23 |
4 |
OE |
$14.39 |
$13,498 |
D/D |
938 |
20,149 |
|
- |
|
| Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
37,876 |
|
- |
|
| Baffi Robert |
EVP, Technical Operations |
• – – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
81,160 |
|
- |
|
| Davis George Eric |
SVP, General Counsel |
• – – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
38,151 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
131,093 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
43,978 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-05-13 |
4 |
S |
$26.68 |
$27,532 |
D/D |
(1,032) |
19,211 |
|
- |
|
| Bate Kenneth |
Director |
– • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
1,875 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
20,243 |
|
- |
|
| Baffi Robert |
EVP, Technical Operations |
• – – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
79,160 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
123,593 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,478 |
|
- |
|
1303 Records found
|
|
Page 27 of 53 |
|
|
1.44 (1.6%) 
